LISATA THERAPEUTICS, INC. Deferred Income Tax Assets, Net
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Income Tax Assets, Net of $0 as of 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2020-03-05
- 2019-12-31: Deferred Income Tax Assets, Net $0.00.
- 2018-12-31: Deferred Income Tax Assets, Net $0.00.
- 2018-03-31: Deferred Income Tax Assets, Net $575.05K.
- 2017-12-31: Deferred Income Tax Assets, Net $575.00K; Deferred Income Tax Assets, Net as first filed $575.05K.
| Period end | Deferred Income Tax Assets, Net | Deferred Income Tax Assets, Net as first filed |
|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-05 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-05 | |
| 2018-03-31 | $575.05K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $575.00K 10-K · filed 2019-03-14 | $575.05K 10-K · filed 2018-03-22 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |